 |
Click HERE for details on the Oligo Fund
Search Term: Oligodendroglioma High Grade
Search results are returned below separately for clinical trials, frequently asked questions, pages on this site, and news articles - scroll down to see them all!
Trials and Noteworthy Treatments
|
|
|
|
|
|
Treatment Next 25
|
|
Location |
|
Last Updated |
|
|
|
Details |
|
Phase I Study of Glioma-Associated Antigen (GAA) Peptide-Pulsed Dendritic Cell Vaccination in Malignant Glioma Patients |
|
Los Angeles, CA |
|
01/24/2010 |
|
|
|
|
|
Details |
|
Phase I/II Study of GP96 Heat Shock Protein-Peptide Complex Vaccine in Patients With Recurrent or Progressive High-Grade Glioma |
|
San Francisco, CA |
|
01/24/2010 |
|
|
|
Details |
|
Phase ll Trial of Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Patients With Atypical or Malignant, Primary or Metastatic Brain Tumors of the Central Nervous System |
|
Los Angeles, CA |
|
01/24/2010 |
|
|
|
|
|
Details |
|
Phase I Dose Escalation Study of Autologous Antigen-Pulsed Dendritic Cell Immunotherapy for Malignant Gliomas (e.g. Glioblastoma Multiforme, Anaplastic Astrocytoma) |
|
Los Angeles, CA
Los Angeles, CA |
|
01/24/2010 |
|
|
|
Details |
|
Phase I/II Trial of Imatinib Mesylate; (Gleevec; ST1571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma |
|
Jacksonville, FL
Ames, IA
Cedar Rapids, IA
Missouri Valley, IA
Sioux City, IA
Moline, IL
Peoria, IL
Urbana, IL
Wichita, KS
Lambertville, MI
Duluth, MN
Saint Louis Park, MN
Billings, MT
Bismarck, ND
Lincoln, NE
Allentown, PA
Danville, PA
Sayre, PA
Spartanburg, SC
Rapid City, SD
Sioux Falls, SD |
|
01/12/2010 |
|
|
|
|
|
Details |
|
ABTC 04-03: A Phase I Study of Vorinostat (Suberolyanilide Hydroxamic Acid [SAHA]) in Combination with Temozolomide in Patients with Malignant Gliomas |
|
San Francisco, CA |
|
01/11/2010 |
|
|
|
Details |
|
Phase II Study of Gamma-Knife Radiosurgery Using Magnetic Resonance Spectroscopy for Target Definition in Patients with Recurrent Glioma |
|
San Francisco, CA |
|
01/11/2010 |
|
|
|
|
|
Details |
|
Phase I study of Vorinostat (SAHA) in combination with temozolomide in patiesnts with malignant gliomas |
|
Houston, TX |
|
12/03/2009 |
|
|
|
Details |
|
Phase I/II adaptive randomized trial of vorinostat, erlotinib and carboplatin in adults with recurrent glioblastoma |
|
Houston, TX |
|
12/03/2009 |
|
|
|
|
|
Details |
|
A PHASE II STUDY OF GLIADEL, CONCOMITANT TEMOZOLOMIDE AND RADIATION, FOLLOWED BY DOSE DENSE THERAPY WITH TEMOZOLOMIDE PLUS BEVACIZUMAB FOR NEWLY DIAGNOSED MALIGNANT HIGH GRADE GLIOMA |
|
Cincinnati, OH |
|
12/02/2009 |
|
|
|
Details |
|
Phase I/II Study of Carboplatin, Melphalan and Etoposide Phosphate in Conjunction with Osmotic Opening of the Blood-Brain Barrier and Delayed Intravenous Sodium Thiosulfate Chemoprotection, in Subjects with Anaplastic Oligodendroglioma or Oligoastrocytoma |
|
Cincinnati, OH |
|
12/02/2009 |
|
|
|
|
|
Details |
|
Phase II Clinical Trial of Patients with High-Grade Glioma Treated with Intra-arterial Carboplatin-based Chemotherapy, Randomized to Treatment with or without Delayed Intravenous Sodium Thiosulfate as a Potential Chemoprotectant against Severe Thrombocytopenia |
|
Cincinnati, OH |
|
12/02/2009 |
|
|
|
Details |
|
Vaccination With Lethally Irradiated Glioma Cells Mixed With GM-K562 Cells in Patients Undergoing Craniotomy For Recurrent Tumor |
|
Boston, MA |
|
09/06/2009 |
|
|
|
|
|
Details |
|
Phase I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas
|
|
Durham, NC |
|
09/05/2009 |
|
|
|
Details |
|
ABTC07-01-Phase I Trial of Aflibercept (VEGF Trap) with Radiation Therapy and Concomitant and Adjuvant
Temozolomide in Patients with Malignant Glioma |
|
San Francisco, CA |
|
07/07/2009 |
|
|
|
|
|
Details |
|
A Phase I Trial and Pharmacokinetic Study of Trabectedin (Yondelis®, ET-743) in Children and Adolescents With Relapsed or Refractory Solid Tumors
|
|
Bethesda, MD |
|
04/22/2009 |
|
|
|
Details |
|
A Phase I/II Trial of ZD6474 for Patients With Recurrent High-Grade and Progressive Low-Grade Gliomas
|
|
Bethesda, MD |
|
04/22/2009 |
|
|
|
|
|
Details |
|
Multiple Ascending Dose (MAD) Study of the IGF-1R Antagonist R1507 Administered as an Intravenous Infusion in Pediatric Patients With Advanced Solid Tumors.
|
|
Bethesda, MD |
|
04/22/2009 |
|
|
|
Details |
|
Phase II Trial of Bevacizumab (Avastin)for Patients With Recurrent High-Grade Glioma |
|
Bethesda, MD |
|
04/21/2009 |
|
|
|
|
|
Details |
|
Phase I Trial of Conditionally Replication-Competent Adenovirus (Delta-24-RGD4C) for recurrent malignant glioma |
|
Houston, TX |
|
04/14/2009 |
|
|
|
Details |
|
A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas |
|
San Francisco, CA |
|
04/06/2009 |
|
|
|
|
|
Details |
|
Quality of Life in Patients with Brain Tumors, Skull Base Tumors & Pituitary Adenomas Undergoing Surgical Resection |
|
Santa Monica, CA |
|
11/29/2008 |
|
|
|
Details |
|
Bevacizumab (Avastin) and Irinotecan (CPT-11) in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma
|
|
San Francisco, CA
Washington, DC
Chicago, IL
Boston, MA
Bethesda, MD
Durham, NC
Philadelphia, PA
Pittsburgh, PA
Memphis, TN
Seattle, WA |
|
11/08/2008 |
|
|
|
|
|
Details |
|
Phase I Trial of Aflibercept (VEGF Trap)with Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Malignant Gliomas |
|
Los Angeles, CA
San Francisco, CA
Boston, MA
Durham, NC
New York, NY
Pittsburgh, PA
Houston, TX
San Antonio, TX
Madison, WI |
|
10/27/2008 |
|
|
|
Details |
|
BIBW 2992 with or without daily temozolomide in the treatment of
patients with recurrent malignant glioma
|
|
Charlottesville, VA |
|
10/20/2008 |
|
|
|
|
|
News Stories
Frequently Asked Questions
|
|
